Učitavanje...

Multiobjective de novo drug design with recurrent neural networks and nondominated sorting

Research productivity in the pharmaceutical industry has declined significantly in recent decades, with higher costs, longer timelines, and lower success rates of drug candidates in clinical trials. This has prioritized the scalability and multiobjectivity of drug discovery and design. De novo drug...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Cheminform
Glavni autor: Yasonik, Jacob
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2020
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7026957/
https://ncbi.nlm.nih.gov/pubmed/33430996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13321-020-00419-6
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!